← Leaderboards
Rita C. R. Perlingeiro
University Of Minnesota
$15,900,680
Attributed
$20,606,525
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,606,525 · 12
By mechanism
R01$13,686,930 · 6
U01$3,269,143 · 1
R42$1,559,533 · 1
RC1$999,659 · 1
R56$423,792 · 1
R21$375,100 · 1
Top collaborators
- Melanie Lynn Graham5 shared
- Michael Kyba5 shared
- Daniel J. Garry3 shared
- Jianyi Zhang3 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Radbod Darabi$3,737,821
- Joseph Mark Metzger$31,677,280
- Atsushi Asakura$2,977,420
- Eunice Oribamise$40,431
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProgenitorProgramsMuscleRegenerative MedicineIn VitroIn VivoGenerationsMesodermMuscle RegenerationInduced Pluripotent Stem CellEmbryoTransplantationEngraftmentSkeletalPluripotent Stem CellsInjuryDystrophinCell TransplantationMuscle FibersBiochemicalMyopathyCell TypeMuscle Satellite Cell
Grant awards (44)
Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD$1,266,814
R42 · FY2025 · AR
Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates$510,051
R01 · FY2025 · AR · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$507,456
R01 · FY2025 · AR · contact PI
Skeletal Muscle Regeneration from Pluripotent Stem Cells$408,767
R01 · FY2025 · AR · contact PI
Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates$622,857
R01 · FY2024 · AR · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$560,261
R01 · FY2024 · AR · contact PI
Skeletal Muscle Regeneration from Pluripotent Stem Cells$408,767
R01 · FY2024 · AR · contact PI
Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates$609,328
R01 · FY2023 · AR · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$516,055
R01 · FY2023 · AR · contact PI
Skeletal Muscle Regeneration from Pluripotent Stem Cells$421,409
R01 · FY2023 · AR · contact PI
Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD$292,719
R42 · FY2023 · AR
Disease Modeling of Skeletaland Cardiac Muscle in DMD/BMD using Patient-Specific iPS Cells$170,500
R21 · FY2023 · AR · contact PI
Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates$600,710
R01 · FY2022 · AR · contact PI
Skeletal Muscle Regeneration from Pluripotent Stem Cells$417,195
R01 · FY2022 · AR · contact PI
Disease Modeling of Skeletaland Cardiac Muscle in DMD/BMD using Patient-Specific iPS Cells$204,600
R21 · FY2022 · AR · contact PI
Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates$605,497
R01 · FY2021 · AR · contact PI
Skeletal Muscle Regeneration from Pluripotent Stem Cells$441,802
R01 · FY2021 · AR · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$353,874
R01 · FY2021 · AR · contact PI
Skeletal Muscle Regeneration from Pluripotent Stem Cells$423,792
R56 · FY2020 · AR · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$364,820
R01 · FY2020 · AR · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$378,372
R01 · FY2019 · AR · contact PI
Stem Cell Biology Training Program$103,848
T32 · FY2019 · GM · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$374,647
R01 · FY2018 · AR · contact PI
Skeletal Muscle Regeneration from Differentiating Pluripotent Stem Cells$334,400
R01 · FY2018 · AR · contact PI
Stem Cell Biology Training Program$188,520
T32 · FY2018 · GM · contact PI
Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors$385,838
R01 · FY2017 · AR · contact PI
Skeletal Muscle Regeneration from Differentiating Pluripotent Stem Cells$334,400
R01 · FY2017 · AR · contact PI
Skeletal Muscle Regeneration from Differentiating Pluripotent Stem Cells$334,400
R01 · FY2016 · AR · contact PI
Midwestern Progenitor Cell Consortium$1,104,105
U01 · FY2015 · HL
Skeletal Muscle Regeneration from Differentiating Pluripotent Stem Cells$334,400
R01 · FY2015 · AR · contact PI
Midwestern Progenitor Cell Consortium$1,098,208
U01 · FY2014 · HL
Skeletal Muscle Regeneration from Differentiating Pluripotent Stem Cells$334,400
R01 · FY2014 · AR · contact PI
Midwestern Progenitor Cell Consortium$1,066,830
U01 · FY2013 · HL
Skeletal Muscle Regeneration from Differentiating Embryonic Stem Cells$315,723
R01 · FY2012 · AR · contact PI
The Role of Endoglin in Hemangioblast Development$377,500
R01 · FY2011 · HL · contact PI
Skeletal Muscle Regeneration from Differentiating Embryonic Stem Cells$315,723
R01 · FY2011 · AR · contact PI
Examining the Therapeutic Potential of iPS cells in Duchenne Muscular Dystrophy$999,659
RC1 · FY2010 · AR · contact PI
The Role of Endoglin in Hemangioblast Development$377,500
R01 · FY2010 · HL · contact PI
Skeletal Muscle Regeneration from Differentiating Embryonic Stem Cells$328,878
R01 · FY2010 · AR · contact PI
The Role of Endoglin in Hemangioblast Development$377,500
R01 · FY2009 · HL · contact PI
Skeletal Muscle Regeneration from Differentiating Embryonic Stem Cells$332,200
R01 · FY2009 · AR · contact PI
The Role of Endoglin in Hemangioblast Development$377,500
R01 · FY2008 · HL · contact PI
Skeletal Muscle Regeneration from Differentiating Embryonic Stem Cells$332,200
R01 · FY2008 · AR · contact PI
The Role of Endoglin in Hemangioblast Development$392,500
R01 · FY2007 · HL · contact PI